Register now by clicking the green “Save My Spot” button and confirm via your email.

Organoids are enabling a growing area of innovative clinical research that has the potential to revolutionize the field of drug discovery and open new approaches to personalized medicine.

In this expert panel discussion — co-hosted by the Center for Connected Medicine (CCM) and the Institute for Precision Medicine at UPMC and University of Pittsburgh — foremost leaders in the field of organoid research will discuss why interest in organoids is increasing and detail some of the exciting use cases for leveraging this innovative technology.

The following topics will be addressed in the discussion:

How 3D human cell culture techniques will improve traditional cell-based research.

Advancements and real-world applications of organoid technology.

Opportunities in drug screening, disease modelling, clinical trial design, and personalized medicine.

Challenges faced in getting organoids into the clinic and how to push the boundaries of organoid research.

Moderated by Ipsita Banerjee, PhD, Professor, Swanson School of Engineering, University of Pittsburgh, the panel includes the following experts:

Gordana Vunjak-Novakovic, PhD, University Professor and the Mikati Foundation Professor of Biomedical Engineering and Medicine, Columbia University

Hans Clevers, MD, PhD, Head of Pharma Research & Early Development, Roche

Mathew Garnett, PhD, Senior Group Leader, Wellcome Sanger Institute

Join us for this discussion on Wednesday, Nov. 15, at 10 a.m. ET, by clicking the green “Save My Spot” button.

Learn more about the Institute for Precision Medicine and the Center for Connected Medicine.

At the Frontier of Clinical Research: How Organoids are Changing the Way Diseases are Studied and Treated